Symbol
| FOSL1
| contributors: mct/npt/shn - updated : 04-12-2012
|
HGNC name
| FOS-like antigen 1
|
HGNC id
| 13718
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in breast cancer in progression | tumoral
|  
|  
| --over
|  
|
in pancreatic cancer | tumoral
|  
|  
| --low
|  
|
in non-small-cell lung cancer with poor survival (Ma 2009) | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| target for therapeutic interventions in malignant gliomas | |
gene ablation can suppress the invasive phenotypes of many tumor cell lines | |
potentially useful in pancreatic tumor targeting or as tumor markers | |
lethality of fra-1-knockout mice can be rescued by specific deletion of Fra-1 only in the mouse embryo | |
autoregulatory loop between JUN and FOSL1 might represent an important determinant for the increased JUN activity and a novel target for therapeutic intervention in tumorigenesis |
| | |
| Ectopic expression of the transcription factor Fra-1 in transgenic mice leads to osteosclerosis | |
fra-1-knockout mice die in utero likely due to placental defects |
|
Mice lacking Fra-1 (fra-1(delta/delta)) are viable and develop osteopenia, a low bone mass disease |